Source: FinanzNachrichten

Resolve BioSciences: Resolve Biosciences Expands Meridian Molecular Cartography Service Program for Virtually Any Species or Tissue Type at AGBT 2023

Customers can now access company's groundbreaking technology without an instrument purchase to quickly generate the industry's highest-quality 3D spatial transcriptomics data Resolve Biosciences, ...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
John Stark's photo - CEO of Resolve Biosciences

CEO

John Stark

CEO Approval Rating

90/100

Read more